3SBio, Inc. (1530)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about 3SBio, Inc. (1530)
Go deeper and ask any question about 1530
Company Performance
Current Price
as of Sep 17, 2024$0.74
P/E Ratio
7.72
Market Cap
$1.78B
Description
3SBio, Inc. operates as an investment holding company, which engages in the development, production, marketing, and sale of biopharmaceutical products. Its products are used in the field of medicine, particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. It operates through the Mainland China and Others geographical segments. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Metrics
Overview
- HQShenyang, LI
- SectorHealth Technology
- IndustryBiotechnology
- Ticker1530
- Price$0.735341+0.37%
Trading Information
- Market Cap$1.78B
- Float75.27%
- Average Daily Volume (1m)4,935,714
- Average Daily Volume (3m)4,512,911
- EPS$0.70
Company
- Revenue$8.64B
- Rev Growth (1yr)8.27%
- Net Income$1.71B
- Gross Margin84.98%
- EBITDA Margin35.01%
- EBITDA$3.02B
- EV$19.61B
- EV/Revenue2.27
- P/E7.72
- P/S1.53
Documents
Factset